Massachusetts Eye and Ear recently opened the Center for Thyroid Eye Disease and Orbital Surgery, a multidisciplinary initiative to address complex conditions affecting the eye sockets, including orbital tumors and thyroid eye disease.
National survey shows it's getting hard to find an ophthalmologist to screen premature babies for eye disease.
Girls with a rare genetic disorder caused by mutations in the Nf1 gene are much more likely to lose their vision than boys with the same mutations. Researchers at Washington University School of Medicine in St. Louis believe estrogen activates immune cells that damage the nerves necessary for sight.
A new study is the first to show that the Parkin gene is turned on when cells are exposed to environmental insults that cause free radical formation and cataract formation. Researchers have discovered that through the removal of mitochondria that are damaged by these environmental insults, Parkin prevents free radical formation in lens cells and increases the ability of the cells to survive exposure to conditions that are associated with aging and the development of many degenerative diseases.
Funding from a National Eye Institute award to the UAB School of Optometry will advance eye care research.
A team of scientists has mapped out how our brains process visuals we don’t even know we’ve seen, indicating that the neuronal encoding and maintenance of subliminal images is more substantial than previously thought.
A common class of drugs for vision loss may actually add to the problem in some patients, according to new research co-led by scientists at The Scripps Research Institute (TSRI).
Older adults with cataracts are more likely to have symptoms of depression, reports a study in the December issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin -- the active compound in hallucinogenic "magic mushrooms."
Audio will be available for an exhibit at UIC
Loss of vision is one of the many dreaded complications of diabetes. Over 5.3 million Americans suffer from diabetes-related retinal disease or diabetic retinopathy. After 20 years of living with diabetes, nearly all type 1 diabetics will have some degree of diabetic retinopathy, as will approximately 60 percent of type 2 diabetics. Some of these patients will experience significant vision loss.
Scientists have found that with minimal training, members of the general public may be able to match the accuracy of experts in interpreting medical images of the eye. The work, published in Translational Vision Science & Technology (TVST), introduces a world where individuals without medical training could contribute to decisions made in the clinic.
Regenerative medicine company jCyte has completed enrollment in a phase I/IIa trial studying the safety of its stem cell therapy for retinitis pigmentosa. Early results are promising.
A new study led by researchers at Massachusetts Eye and Ear found that vestibular thresholds begin to double every 10 years above the age of 40, representing a decline in our ability to receive sensory information about motion, balance and spatial orientation. The report was published online ahead of print in Frontiers in Neurology.
The American Academy of Optometry (AAO) recently announced Nova Southeastern University (NSU) College of Optometry Professor Rachel A. "Stacey" Coulter, O.D., M.S.Ed., FAAO, FCOVD, as the recipient of the prestigious 2016 William Feinbloom Award. Dr. Coulter was recognized at the Academy 2016 Anaheim Awards Ceremony on November 11, 2016.
Young adults now have access to an outpatient procedure that can help prevent progressive vision loss and avoid corneal transplants. University of Michigan Health System Kellogg Eye Center has been on the forefront of studying and providing corneal cross-linking.
It was Labor Day 2015 when Rosetta Ivey-Foster, a 76-year-old retired bank clerk, learned first-hand how quickly diabetes can deteriorate vision. Swift action restored most of her eyesight.
Dr. Robert Ritch has been selected to receive the 2017 Joanne G. Angle Service Award from the Association for Research in Vision and Ophthalmology (ARVO). This is the highest honor from the leading eye and vision research organization in the world.
Robert Selby, a legally blind 54-year-old man from Hazelwood, Missouri, has retinitis pigmentosa, a rare, inherited condition that progressively robs sight. But with the help of an artificial retina he hopes to be able to get around more independently and safely.
An international team of scientists led by the University of Michigan has discovered a new type of photoreceptor—only the third to be found in animals—that is about 50 times more efficient at capturing light than the rhodopsin in the human eye.
A study using Barbies and Transformers finds that men are better at recognizing Transformer faces while women are better at recognizing Barbie faces, supporting the theory that experience plays an important role in facial recognition.
NYU Langone receives $15 million for a five-year research grant from the National Eye Institute to evaluate treatment for shingles of the eye.
Researchers at Queen’s University Belfast together with University of St Andrews and Aberdeen have found that the procedure used to remove cataracts is more successful than current standard treatments with laser in treating Primary Angle-Closure Glaucoma – a leading cause of irreversible blindness worldwide.
Bacteria in your intestines may play an important role in determining if you will develop blinding wet Age-related Macular Degeneration (AMD).
Columbia University researchers slowed vision loss in mice with a form of retinitis pigmentosa by reprogramming the metabolism of photoreceptors in the retina.
Aaron W. McGee, Ph.D., assistant professor at the UofL School of Medicine, has received the Disney Award for Amblyopia Research from Research to Prevent Blindness. McGee will use the award to investigate approaches for improving recovery from amblyopia, or “lazy eye."
Michael Crair, Yale University, and Carol Mason, Columbia University, have co-authored a report published online today in the Journal of Neuroscience. “Reconnecting Eye to Brain” is a comprehensive assessment of what scientists know about optic nerve development, regeneration, and reconnection. The report was based on input gathered during the Oct. 16, 2015, panel discussion, titled “Reconnecting Neurons in the Visual System,” sponsored by the National Eye Institute Audacious Goals Initiative (AGI). The panel comprised two dozen leading experts on neural development and regeneration.
• The hypothesis accepted until now was based in the fact that radiation from the Sun has its maximum intensity near the absorption peaks of human vision • This study uses information theory and the entropy of radiation to explain why human vision has evolved to adapt to solar radiation
A new study in the American Journal of Ophthalmology reports that low-cost, widely available eye drops are just as effective as antibiotics in treating bacterial keratitis -- a significant finding for developing nations where antibiotics are too costly.
Massachusetts Eye and Ear has appointed Daniel B. Polley, Ph.D., leading neuroscientist and hearing researcher, as the first Director of the Lauer Tinnitus Research Center. In this role, Dr. Polley will direct the Center’s efforts to advance research to better understand and treat tinnitus (or “ringing in the ears”), a condition affecting more than 50 million Americans and for which there are currently no widely effective treatments.
RPB-supported vision researchers at Washington University School of Medicine in St. Louis have contributed key data to a new study that identifies a natural compound that slows typical signs of aging in mice. The study, published today in Cell Metabolism, shows that older mice drinking water supplemented with NMN (nicotinamide mononucleotide) resembled younger mice in measures of metabolism and energy production.
Two Case Western Reserve University School of Medicine researchers have received grants totaling $40,000 from Ann Arbor-based Eversight, a global nonprofit network of eye banks. The CWRU projects are aimed at helping glaucoma patients and those with Fuchs’ endothelial corneal dystrophy.
Protamine—a natural protein with a proven safety record—may be useful in developing new types of disinfectant solutions for contact lenses, according to a study published in the November issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
As the end of daylight saving time draws near, ophthalmologists at the Vanderbilt Eye Institute want to focus on a real issue—dim-light driving situations that can endanger drivers and pedestrians.
Upstate researchers Andrea S. Viczian, Ph.D., and Michael E. Zuber, Ph.D., and their colleagues, have identified two genes—Tbx3 and Pax6—that together are sufficient to start the process of eye development.
Roughly 30,000 sports-related eye injuries serious enough to end in a visit to the emergency room occur each year in the United States, and the majority happen to those under the age of 18, new Johns Hopkins Bloomberg School of Public Health-led research suggests.
Researchers at Binghamton University, led by PhD student Anastacia Kudinova, aimed to examine whether physiological reactivity to emotional stimuli, assessed via pupil dilation, served as a biological marker of risk for depression recurrence among individuals who are known to be at a higher risk due to having previous history of depression. Participants were 57 women with a history of major depressive disorder (MDD). The researchers recorded the change in pupil dilation in response to angry, happy, sad and neutral faces. The team found that women’s pupillary reactivity to negative (sad or angry faces) but not positive stimuli prospectively predicted MDD recurrence.
To celebrate its revolutionary impact on eye care around the world, the Associatio n for Research in Vision and Ophthalmology (ARVO) has independently produced a series of short videos, educational tools and advocacy resources on the discovery and development of optical coherence tomography (OCT).
Mary Ann Stepp, Ph.D., professor of anatomy and regenerative biology and of opthalmology at the George Washington University School of Medicine and Health Sciences, received a $2.8 million grant to continue her 27 years of research on corneal wound healing.
Daniel Palanker, PhD, and Pradeep Y. Ramulu, MD, PhD, are recognized for their significant achievements in vision research.
In the past decade, ophthalmologists have been prescribing nutritional supplements to be taken daily to prevent or slow vision loss from age-related macular degeneration (AMD). Now, using nutritional supplements for eye health has become more common. But does increasing the recommended dose increase your protection? A case report appearing online in JAMA Ophthalmology from the Moran Eye Center at the University of Utah reveals what can happen when a patient takes more of a supplement than their body needs.
A study sheds new understanding on the mechanisms of the diabetic retinopathy - which is the most prominent complication of diabetes and the leading cause of blindness in working age individuals - as it uncovered a program of accelerated aging of the neurons, blood vessels and immune cells of the retina in areas where blood vessels had been damaged.
What causes vision loss in glaucoma? There are two common answers that at first may seem disparate: the first is pressure, as in elevated ocular pressure, and the second is damage to the optic nerve, which is the structure that sends visual information to the brain. Both answers are correct.
Roshni Vasaiwala, MD, an ophthalmologist who specializes in the care and management of difficult corneal diseases, has joined Loyola Medicine.
Visual hallucinations ... everyone has heard of them, and many people have experienced the sensation of "seeing" something that isn't there. But studying the phenomenon of hallucinations is difficult: they are irregular, transitory, and highly personal--only the person experiencing the hallucination knows what he or she is seeing, and representations of what's being seen are limited to verbal descriptions or drawings.
People with diabetes are at increased risk of developing serious eye diseases, yet most do not have sight-saving annual eye exams, according to a large study presented this week at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology. This is especially timely as the Academy is reiterating the importance of eye exams during the month of November, which is observed as Diabetic Eye Disease Awareness Month.
To provide a better view of difficult to see tissue, Japanese researchers have miniaturized an imaging probe to fit inside a needle that can be inserted into the eye during eye surgery. The probe was used without complications in three human patients, as described in an article published in Investigative Ophthalmology & Visual Science (IOVS).
An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest five-year results from a study presented at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology. Transplantation of one layer of the cornea may help people with keratoconus avoid or delay full corneal transplantation and other potentially risky procedures, according to the researchers. They say the technique may enable those with advanced keratoconus to tolerate extended contact lenses wear, which is traditionally a challenge for people with the condition.
Researchers are testing cutting-edge treatments for people who want to see up close without reading glasses and finding promising results, according to studies presented this week at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology. A new method that uses lasers to reshape a small part of the cornea, and a separate technique using painless electrostimulation, may be effective in treating presbyopia, the blurry near vision people develop around age 40.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right